Results 1 to 10 of about 68,812 (293)

Alterations in the CD56− and CD56+ T Cell Subsets during COVID-19

open access: yesInternational Journal of Molecular Sciences, 2023
The effectiveness of the antiviral immune response largely depends on the activation of cytotoxic T cells. The heterogeneous group of functionally active T cells expressing the CD56 molecule (NKT-like cells), that combines the properties of T lymphocytes and NK cells, is poorly studied in COVID-19.
Julia D. Vavilova   +15 more
openaire   +3 more sources

Prognostic significance of CD56 expression in newly diagnosed multiple myeloma and its correlation with clinicopathological features [PDF]

open access: yesFrontiers in Oncology
ObjectiveTo investigate the correlation of CD56 expression with clinical prognosis and adverse prognostic indicators in patients with newly diagnosed multiple myeloma (NDMM).MethodsWe conducted a retrospective cohort study of 153 NDMM patients treated at
Pei Pei   +12 more
doaj   +2 more sources

Allo-HSCT Might Improve Long-Term Survival in Patients with CD56-Positive AML [PDF]

open access: yesJournal of Blood Medicine
Xiaotong Zhu, Yuting Sun, Yanyan Chen, Raj Singh Dhurel, Chen Zhang, Yutong Xie, Man Ni, Wei Chen, Huanxin Zhang, Qingyun Wu, Depeng Li, Bin Pan, Zhiling YanDepartment of Hematology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu ...
Zhu X   +12 more
doaj   +2 more sources

Phenotypic Profile of Peripheral Blood NK Cells under Culturing with Trophoblast Cells and IL-15 and IL-18 Cytokines

open access: yesМедицинская иммунология, 2021
Natural killer cells (NK cells) are innate immunity lymphocytes. NK cell differentiation is controlled by the cellular microenvironment and locally produced cytokines, including IL-2, IL-15 and IL-18.
V. A. Mikhailova   +7 more
doaj   +1 more source

CD56-positive diffuse large B-cell lymphoma: comprehensive analysis of clinical, pathological, and molecular characteristics with literature review

open access: yesRadiology and Oncology, 2023
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma. The expression of CD56 in DLBCL is highly unusual. Little is known about its incidence and clinical importance.
Gasljevic Gorana   +5 more
doaj   +1 more source

Prognostic significance of CD56 expression in patients with multiple myeloma: a meta-analysis

open access: yesHematology, 2022
Objectives Several studies have demonstrated the expression status of CD56 was associated with prognosis in multiple myeloma (MM) patients, the prognostic significance remains controversial.
Lijuan Zhang   +6 more
doaj   +1 more source

Diagnostic role of immunohistochemical markers CK19 and CD56 in thyroid neoplasms

open access: yesMGM Journal of Medical Sciences, 2023
Introduction: Thyroid cancer is the most common type of endocrine cancer, with an increasing prevalence. The possibility of a malignant neoplasm is the primary concern in people with thyroid nodules. The presence of a plethora of variants complicates the
Pallavi Priyadarshini   +2 more
doaj   +1 more source

Placental markers of miscarriage

open access: yesPatologìâ, 2021
Successful implantation involves a high degree of development of spiral arteries, combined with high proliferative activity, which ensures the formation of a healthy placenta, full uterine-placental circulation, and the birth of a healthy child.
A. A. Zhyvetska-Denysova   +5 more
doaj   +1 more source

Clinical findings and immunophenotypic profile of plasma cell leukemia: a retrospective study in a comprehensive cancer center in Turkey

open access: yesMedicine Science, 2021
Plasma cell leukemia (PCL) is a rare (1-2 %) aggressive plasma cell dyscrasia (PCD) with a poor prognosis and characterized by the presence of more than 20% circulating plasma cells (PCs).
Nurgul Ozcan   +7 more
doaj   +1 more source

Functional Phenotypes of Human Vγ9Vδ2 T Cells in Lymphoid Stress Surveillance

open access: yesCells, 2020
Butyrophilin and butyrophilin-like proteins select γδ T cells and direct the migration of γδ T cell subsets to distinct anatomical sites. γδ T cells expressing Vδ2 paired with Vγ9 (Vγ9Vδ2 T cells) are the
Oliver Nussbaumer, Martin Thurnher
doaj   +1 more source

Home - About - Disclaimer - Privacy